CN114230681A - A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof - Google Patents
A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof Download PDFInfo
- Publication number
- CN114230681A CN114230681A CN202111422635.7A CN202111422635A CN114230681A CN 114230681 A CN114230681 A CN 114230681A CN 202111422635 A CN202111422635 A CN 202111422635A CN 114230681 A CN114230681 A CN 114230681A
- Authority
- CN
- China
- Prior art keywords
- exopolysaccharide
- column
- desalting
- extract
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 73
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 73
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 73
- 239000000284 extract Substances 0.000 title claims abstract description 41
- 208000035240 Disease Resistance Diseases 0.000 claims abstract description 10
- 241000193388 Bacillus thuringiensis Species 0.000 claims abstract description 9
- 229940097012 bacillus thuringiensis Drugs 0.000 claims abstract description 9
- 229920002444 Exopolysaccharide Polymers 0.000 claims description 98
- 239000000243 solution Substances 0.000 claims description 50
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 35
- 238000011033 desalting Methods 0.000 claims description 32
- 239000006228 supernatant Substances 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000011282 treatment Methods 0.000 claims description 24
- 238000005119 centrifugation Methods 0.000 claims description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 238000001742 protein purification Methods 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 21
- 239000008103 glucose Substances 0.000 claims description 21
- 238000001641 gel filtration chromatography Methods 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 238000004255 ion exchange chromatography Methods 0.000 claims description 17
- 238000011068 loading method Methods 0.000 claims description 17
- 238000005349 anion exchange Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 13
- 239000012498 ultrapure water Substances 0.000 claims description 13
- 239000003480 eluent Substances 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- 238000000746 purification Methods 0.000 claims description 10
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 claims description 9
- 238000005227 gel permeation chromatography Methods 0.000 claims description 8
- 239000011148 porous material Substances 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 7
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 229930182830 galactose Natural products 0.000 claims description 7
- 229940097043 glucuronic acid Drugs 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000012506 Sephacryl® Substances 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 241000221696 Sclerotinia sclerotiorum Species 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000002523 gelfiltration Methods 0.000 claims description 5
- 108010067770 Endopeptidase K Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 150000003839 salts Chemical group 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 3
- 239000006286 aqueous extract Substances 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 17
- 239000012153 distilled water Substances 0.000 description 16
- 239000001963 growth medium Substances 0.000 description 16
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical group CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 16
- 150000002772 monosaccharides Chemical group 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 11
- 125000003729 nucleotide group Chemical group 0.000 description 11
- 239000008223 sterile water Substances 0.000 description 10
- 238000013518 transcription Methods 0.000 description 10
- 230000035897 transcription Effects 0.000 description 10
- 238000004108 freeze drying Methods 0.000 description 9
- 230000019491 signal transduction Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000005571 anion exchange chromatography Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
- 239000005977 Ethylene Chemical group 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- HOWHQWFXSLOJEF-MGZLOUMQSA-N systemin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H]2N(CCC2)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CCC1 HOWHQWFXSLOJEF-MGZLOUMQSA-N 0.000 description 5
- 108010050014 systemin Proteins 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 3
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 3
- 238000000861 blow drying Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 238000000569 multi-angle light scattering Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 241000894007 species Species 0.000 description 3
- XOSXWYQMOYSSKB-LDKJGXKFSA-L water blue Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC(C=C2)=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C(C=C2)=CC=C2S([O-])(=O)=O)=CC(S(O)(=O)=O)=C1N.[Na+].[Na+] XOSXWYQMOYSSKB-LDKJGXKFSA-L 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000013365 molecular weight analysis method Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 101150028074 2 gene Proteins 0.000 description 1
- YCRPAFAWTMUXCW-UHFFFAOYSA-N 2,2,2-trichloroacetic acid;hydrate Chemical compound O.OC(=O)C(Cl)(Cl)Cl YCRPAFAWTMUXCW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 244000060924 Brassica campestris Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000034628 Celiac artery compression syndrome Diseases 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- -1 salt ion Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Sustainable Development (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Emergency Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides an extracellular polysaccharide extract, an extracellular polysaccharide and application thereof. The extract is extracted from bacillus thuringiensis, mainly comprises extracellular polysaccharide and can induce plants to generate system disease resistance to plant fungal diseases.
Description
Technical Field
The invention provides an extracellular polysaccharide extract, in particular to an extracellular polysaccharide extract extracted from bacillus thuringiensis, which can induce rape to generate disease resistance.
Background
The extracellular polysaccharide of bacteria is a polysaccharide mixture which is synthesized by bacteria in the process of growth and metabolism and secreted to the extracellular part, and is a long-chain high-molecular polymer which is polymerized by the same or different monosaccharide units through glycosidic bonds. Exopolysaccharides (EPSs) produced by bacteria exist mainly in two forms, Capsular Polysaccharides (CPS) tightly bound to the cell surface and mucopolysaccharides ("Slime"), also called Free Exopolysaccharides (EPS), secreted extracellularly as mucus, with a small amount of Free exopolysaccharides being the main constituent of the biofilm as a water-soluble matrix. The way of distinguishing capsular polysaccharide from free exopolysaccharide is not absolute by the tight degree of exopolysaccharide binding with cells, and a small amount of capsular polysaccharide is not stably connected with cell surface phospholipid and can be released into a culture medium to become free exopolysaccharide, and the free exopolysaccharide can become a component of capsular polysaccharide due to the close contact with cells. The distribution of these extracellular polymeric substances is influenced by the natural growth environment of the cells, such as the chemical properties of the culture solution, the abundance of nutrients, the growth period of the cells, and the like.
The presence of the outermost capsular polysaccharide or extracellular free polysaccharide of bacteria results in an additional barrier between the cell membrane and the external environment. The diversity of chemical compositions of polysaccharides, such as monosaccharide compositions, results in differences in the structures of different species of the same flora, and the diversity of biological functions of the polysaccharides. In addition, some physicochemical properties of the exopolysaccharide, such as stability, consistency, flocculation, suspension, film forming property, water holding capacity and the like, make the exopolysaccharide widely applied to different industrial industries, such as food industry, cosmetic industry, pharmaceutical industry, petroleum industry, mining industry and the like.
Except for a few gram-positive bacteria, most bacterial exopolysaccharides are transported intracellularly for synthesis. Its biosynthesis is carried out in stages: first, sugar nucleotides are assembled into "chemical" oligosaccharide repeat units under the action of glycosyltransferases; the chemical repeat units are subsequently polymerized in the presence of a polymerase to form "biological" repeat units such as macromolecular polysaccharides. A large number of sugar residues make up the backbone of the polysaccharide and in addition include some non-sugar substituents, such as acetate, pyruvate, succinate, phosphate, and the like. The composition, chemical and physical properties of extracellular polysaccharides of bacteria determine the main conformation of the polysaccharides, and these properties are quite different from one bacterial species to another. Different types of capsular polysaccharides can be produced by the same species of bacterial flora. Thus, different biological functions are gradually discovered, and the extracellular polysaccharide can be hidden on the surface of bacteria under natural conditions, can be used as a bonding agent to interact with other bacteria surface or lower substances, can protect the bacteria against the stress of the external environment, can be used as a matrix for bacteria to aggregate at the rhizosphere to form a biofilm and maintain the stability of the biofilm, and can be used as a signal molecule for the bacteria to exchange with the outside. In a severe growth environment, bacteria can utilize extracellular polysaccharide secreted by the bacteria as a carbon source. The production of extracellular polysaccharide is low, so that the market application of the polysaccharide is limited.
In recent years, with the rapid development of chemistry, molecular biology and imaging technology, the potential functions of extracellular polysaccharides of bacteria still need to be explored.
Disclosure of Invention
The invention provides an exopolysaccharide extract, which is obtained by the following steps:
firstly), adjusting the pH value of fermentation liquor of the Bacillus thuringiensis IPPBiotSR045 to 8-9, then carrying out first centrifugation, and collecting first supernatant after the first centrifugation;
secondly) adding trichloroacetic acid or trichloroacetic acid water solution into the first supernatant, thereby treating the first supernatant with trichloroacetic acid to obtain a first treatment solution, then carrying out second centrifugation, and collecting a second supernatant after the second centrifugation;
and thirdly) adjusting the pH value of the second supernatant to 6-7, adding ethanol into the second supernatant to obtain a second treatment solution, precipitating the second treatment solution, then carrying out third centrifugation, and collecting precipitate after the third centrifugation, wherein the precipitate is the wet crude extracellular polysaccharide extract.
In a specific embodiment, the method further comprises the steps of removing residual protein, desalting, ion exchange chromatography and gel filtration chromatography of the crude exopolysaccharide extract in sequence.
In a specific embodiment, the residual protein is removed using proteinase K; using HiPrepTM26/10Desalting the crude extracellular polysaccharide extract with residual protein removed with Desalting column to obtain desalted chromatography liquid; purifying the desalted chromatographic solution by using a HiTrap Q HP Column anion exchange Column to obtain an ion chromatographic solution;purifying the ion chromatography liquid by using a HiLoad 26/600 Sephacryl S-100column gel filtration layer column to obtain gel chromatography liquid with a plurality of hole sites; mixing the gel chromatography liquid containing the extracellular polysaccharide hole sites, and concentrating by using a freeze drying instrument to obtain a wet pure extracellular polysaccharide extract; or drying into powder with freeze drying instrument to obtain dried pure exopolysaccharide extract.
In one embodiment, HiPrep is utilizedTM26/10 desaling Desalting column for crude exopolysaccharide extract with residual protein removed comprises the following steps:
1) centrifuging the crude extracellular polysaccharide extract water solution with residual protein removed at 10000r/min for 20min to remove impurities;
2) subjecting the desalting column HiPrepTM26/10 desaling loading protein purification systemIn the method, the ultra-pure water is used for cleaning the HiPrep containing desalting columnTM26/10 desaling-containing protein purification system
3) Filtering the crude extracellular polysaccharide extract water solution with residual protein removed by using a bacterial membrane to obtain a filtered extract water solution, and loading 7mL of the filtered extract water solution to a desalting column at the flow rate of 10mL/min each time;
4) according to UV490Respectively starting and ending the peak value and the peak position of the salt peak, and collecting samples flowing out of the desalting column to obtain a desalting chromatographic solution;
the purification of the desalted chromatography liquid by using a HiTrap Q HP Column anion exchange Column comprises the following steps:
I) installing the anion exchange column in a protein purification systemIn addition, the ultrapure water is utilized to clean the protein purification systemAt the same time, 2mol/L sodium chloride aqueous solution is used for balancing the anion exchange column;
II) after the concentration of the extracellular polysaccharide in the desalted chromatographic solution is 10-15mg/mL, loading the desalted chromatographic solution to an anion exchange column by using an S1 loading pump, wherein the loading amount is 15-20mL each time, the flow rate is 2.0mL/min, and meanwhile, manually collecting by using a 96-hole deep-hole plate, namely 1.7 mL/tube;
III) after the sample loading is finished, washing the anion exchange column by ultrapure water with 5 times of the column volume of the anion exchange column;
IV) carrying out linear elution with the concentration of 0-100% by using 2mol/L sodium chloride aqueous solution for 20min at the flow rate of 5mL/min to obtain an eluent;
v) detecting the hole site of the eluent containing the exopolysaccharide by using a phenol-sulfuric acid method, mixing the eluent containing the hole site of the exopolysaccharide, and concentrating by using a freeze dryer to obtain an ion chromatography liquid;
the purification of the ion chromatography liquid by using HiLoad 26/600 Sephacryl S-100column gel filtration chromatography comprises the following steps:
A) installing the gel filtration chromatography column in a protein purification systemIn the above, the protein purification system was washed with 0.15mol/L aqueous sodium chloride solutionAnd a gel filtration chromatography column;
B) taking 5mL of ion chromatography liquid each time, manually loading the sample to a gel filtration chromatography column, immediately collecting a sample flowing out of the gel filtration chromatography column by using a 96-well plate, wherein the flow rate of a system is 0.5mL/min, 0.5mL is collected in each hole, and stopping collecting 180mL in total to obtain gel chromatography liquid;
C) detecting the hole position of the gel chromatographic solution containing the extracellular polysaccharide by using a phenol-sulfuric acid method, and mixing the gel chromatographic solution containing the hole position of the extracellular polysaccharide; concentrating with freeze drying instrument to obtain wet pure extracellular polysaccharide extract; or drying into powder with freeze drying instrument to obtain dried pure exopolysaccharide extract.
In a specific embodiment, in step 2), the mass/volume content of the trichloroacetic acid and the first supernatant is between 0.4% and 0.5%.
In a specific embodiment, in step 3), the volume of ethanol added to the second supernatant is 3 to 3.5 times the volume of the second supernatant.
In one embodiment, in step 2), the first treatment liquid is left at a temperature of 25 to 35 ℃ for 1.5 to 3 hours.
In one embodiment, in step 3), the second treatment solution is left at 2 to 8 ℃ for 12 to 20 hours.
In a specific embodiment, the centrifugation speed of the first centrifugation, the second centrifugation, and the third centrifugation is independently 6000 to 8000r/min, the centrifugation temperature is independently 3 to 10 ℃, and the centrifugation time is independently 30 to 40 min.
In one embodiment, the culture medium for culturing the bacillus thuringiensis is one of an LB culture medium, a glucose-producing culture medium with glucose as a substrate, and a sucrose-producing culture medium with sucrose as a substrate.
In one embodiment, the precipitate is freeze-dried to obtain a dry crude exopolysaccharide extract.
The second invention provides an exopolysaccharide, wherein the Mw is 66.2kDa, the Mn is 42.7kDa, the Mz is 87.6kDa and the polydispersity is 1.55, the exopolysaccharide is composed of mannose, glucuronic acid, glucose and galactose, wherein the relative molar ratio of the mannose, the glucuronic acid, the glucose and the galactose is 55.77: 5.67: 3.70: 1. the relative molar ratio of the monosaccharides can be converted into the mass percentage content, and after the conversion, the mass of the exopolysaccharide is taken as 100%, the content of mannose is 83.77%, the content of glucuronic acid is 9.18%, the content of glucose is 5.56%, and the content of galactose is 1.49%.
The third invention provides the application of the extract or the exopolysaccharide in the second invention in inducing plant disease resistance.
In a specific embodiment, the plant is canola.
In one embodiment, the disease resistance is against a disease caused by sclerotinia sclerotiorum.
The invention has the beneficial effects that:
it is found for the first time that exopolysaccharides produced by Bt can induce plants to produce systemic disease resistance to plant fungal diseases, and the disease resistance is generated by the activation of jasmonic acid and ethylene signal pathways.
Drawings
FIG. 1 shows OD of extracellular polysaccharide-containing eluents at different pore sites after anion exchange chromatography490The value is obtained.
FIG. 2 shows OD of extracellular polysaccharide-containing eluents at different pore sites after gel filtration chromatography490The value is obtained.
Fig. 3 shows the full wavelength scan results of pure exopolysaccharides purified from IPPBiotSR045 strain.
Fig. 4 shows the results of ion chromatography detection of standard monosaccharides and exopolysaccharides purified from IPPBiotSR045 strain. Wherein the upper curve is the ion chromatography result of a standard monosaccharide; the lower curve is the ion chromatography result of exopolysaccharides purified from IPPBiotSR045 strain.
Fig. 5 shows exopolysaccharide-induced disease resistance of canola systems purified from IPPBiotSR045 strain.
FIG. 6 shows the transcription of jasmonic acid signal pathway related gene BnHEL.
FIG. 7 shows the transcription of jasmonic acid/ethylene signal pathway related gene BnPDFF 1.2.
FIG. 8 shows the transcription of the salicylic acid signal pathway related gene BnWRKY 70.
Detailed Description
The present invention is further illustrated by the following examples, which are intended to be purely exemplary of the invention and are not to be construed as limiting the invention in any way.
The reagents in the examples of the present invention were all commercially available unless otherwise specified.
Peptone, yeast extract, PDA, MS medium solid powder were purchased from Beijing Bingda Biotech Ltd.
Glucose, sucrose, aniline blue, bengal red were purchased from sigma.
Other biochemical reagents are all commercially available domestic or imported analytical pure or electrophoretic pure chemical reagents.
Liquid LB medium: 10.0g peptone, 5.0g yeast extract, 10.0g sodium chloride, 1.0L volume by volume with distilled water, and sterilizing at 121 deg.C for 20 min.
A sugar production culture medium using glucose as a substrate: 10.0g glucose, 5.0g yeast extract, and distilled water with volume value of 1.0L, sterilizing at 115 deg.C for 30 min.
Sugar production medium with sucrose as substrate: 20.0g sucrose, 5.0g yeast extract, and distilled water with volume value of 1.0L, sterilizing at 115 deg.C for 30 min.
Aniline blue selective medium: 0.05g/L aniline blue solid and 15.0g/L agar powder are respectively added into the two sugar production culture mediums.
PDA solid medium: 39.0g PDA powder was dissolved in 1.0L distilled water, and sterilized with distilled water at 115 ℃ for 15min to give a volume value of 1.0L.
Solid culture medium of Bengal red: 0.5 wt% of peptone, 1 wt% of sodium chloride, 1 wt% of glucose, 0.1 wt% of monopotassium phosphate, 0.05 wt% of magnesium sulfate, 2 wt% of agar, 3mL of 1 wt% of Bengal mother liquor, 1.0L of volume value by using distilled water, and sterilizing for 15min at 115 ℃. Before use, streptomycin is coated by 50 mug/mL according to requirements.
MS culture medium: the MS culture medium solid powder is subjected to volumetric value of 1.0L by using distilled water and sterilized for 15min at 121 ℃.
Extracting and quantifying reagent for extracellular polysaccharide:
1mol/L sodium hydroxide: 4.0g of sodium hydroxide was dissolved in 100mL of sterile distilled water and stored at room temperature.
2mol/L hydrochloric acid: 500mL of sterile distilled water was added to 100mL of concentrated hydrochloric acid, and the mixture was stored at room temperature.
95% ethanol: 950mL of absolute ethanol was added with 50mL of sterile distilled water and stored at room temperature.
80% phenol: 80.0g of phenol was dissolved in 50mL of sterile distilled water, and the volume was adjusted to 100mL with sterile distilled water, and the solution was stored at 4 ℃ in the dark.
The main apparatus comprises: a full-automatic moist heat sterilizer, SANYO, Japan, model MLS-3780/MAC 350P; superclean bench, Beijing Hardong corporation, model DL-CJ-2N; a constant temperature incubator, Shanghai laboratory Instrument Master, model DHP 120; temperature controlled shaker, model MAXQ5000, manufactured by Thermo corporation, USA; a bench centrifuge, eppendorf, germany, model 5415C; high speed centrifuge, Beckman, USA, model Avanti J-26 xp; freeze dryer VirTis, usa.
The cabbage type rape (Brassica campestris L.) is Shanghai green.
The rape planting site is as follows: greenhouse of pilot plant base in corridor of institute of plant protection of Chinese academy of agricultural sciences. The planting mode is as follows: the rape seeds are subjected to surface disinfection by using 75% alcohol, 5% sodium hypochlorite and sterile water in sequence, and are uniformly sowed on an MS (Murashige and Skoog, MS) solid culture medium plate. After about 10 days, the seedlings were transplanted into seedling pots (diameter 6.0cm, depth 10.0cm), and planting soil included nutrient soil and vermiculite (ratio 2: 1). The culture conditions are as follows: the illumination time is 14h, and the illumination intensity is 7,000 Lux; the dark time was 10 h. Growth temperature: about 22 deg.c.
The IPPBiotSR045 strain is preserved in the China general microbiological culture Collection center of China Committee for culture Collection of microorganisms with the preservation number of CGMCC No.13302, the preservation date of 2016, 11 and 15 days, and the preservation addresses of: the institute of microbiology, national academy of sciences No.3, Xilu No.1, Beijing, Chaoyang, Beijing. The system is classified as Bacillus thuringiensis (Bacillus thuringiensis).
Example 1
1. Extraction of crude exopolysaccharides
(1) Inoculating 10 mu L of glycerol strain of Bacillus thuringiensis IPPBiotSR045 into 5mL of liquid LB culture medium, and activating at 30 ℃ and 220r/min for 10h to obtain activated bacteria liquid;
(2) transferring the activated bacterium liquid into 100mL of liquid LB culture medium by the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
(3) collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 8.5, 4 ℃ and 7000r/min by using 1mol/L NaOH, centrifuging for 30min, and collecting a first supernatant;
(4) adding 1/10 volume of 5 wt% trichloroacetic acid aqueous solution into the first supernatant, and denaturing the protein at 25 deg.C for 2 hr;
(5) centrifuging at 4 deg.C for 30min at 7000r/min, collecting second supernatant, and adjusting pH to 6.5;
(6) adding 3 times volume of absolute ethyl alcohol to precipitate for 12 hours in a refrigerator at 4 ℃ overnight to generate brown precipitate;
(7) centrifuging at 4 deg.C for 30min at 7000r/min, discarding supernatant, and freeze drying brown precipitate to obtain crude exopolysaccharide powder.
2. Quantification of exopolysaccharides
2.1 preparation of Standard Curve
Firstly, preparing a glucose mother solution: 0.1g of glucose is dissolved in 250mL of sterile distilled water and stirred evenly to prepare a glucose mother liquor.
Then glucose mother liquor is utilized to prepare glucose standard liquor with different concentration gradients, then 0.1mL of 98% concentrated sulfuric acid and 0.5mL of 6 wt% phenol aqueous solution are respectively added into the glucose standard liquor with different concentration gradients, and sterile distilled water is added to make up to a system of 0.8 mL. Slowly mixing, cooling, standing at room temperature for 20min, measuring light absorption value at 490nm in an enzyme labeling plate at 200 μ L, replacing sample with sterile distilled water as blank control, and repeating three times for each treatment group to draw a standard curve.
2.2 phenol-sulfuric acid method of quantitation
Diluting with different gradients (to make OD)490nmValue between 0.2 and 1.0), adding 0.1mL of concentrated sulfuric acid and 0.5mL of 6 wt% of phenol aqueous solution into a centrifuge tube, then supplementing to 0.8mL of system with sterile distilled water, mixing uniformly, cooling, standing at room temperature for 20min, taking 200 mu L of the mixture in an enzyme label plate, measuring the light absorption value at 490nm, and calculating the content of the extracellular polysaccharide in the sample according to a standard curve drawn by 2.1.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 210mg/L of bacterial liquid.
Example 2
Crude exopolysaccharide extraction was the same as in subsection 1 of example 1, except that:
in the step (2), respectively transferring the activated bacterium liquid into 100mL of liquid culture medium of a sugar production culture medium taking glucose as a substrate by using the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
in the step (3), respectively collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 8, 3 ℃ and 6000r/min by using 1mol/L NaOH, centrifuging for 40min, and collecting a first supernatant;
in the step (4), 1/10 volumes of 4 wt% trichloroacetic acid aqueous solution is added into the first supernatant, and the protein is denatured for 3 hours at 35 ℃;
centrifuging at 3 deg.C and 8000r/min for 30min in step (5), collecting second supernatant, and adjusting pH to 6;
in the step (6), adding 3 times of volume of absolute ethyl alcohol to precipitate for 16 hours at 2 ℃ in a refrigerator;
and (7) centrifuging at 3 ℃ and 6000r/min for 40min, discarding supernatant, and freeze-drying the precipitate to obtain crude exopolysaccharide powder.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 200mg/L of bacterial liquid.
Example 3
Crude exopolysaccharide extraction was the same as in subsection 1 of example 1, except that:
in the step (2), respectively transferring the activated bacterium liquid into 100mL of liquid culture medium of a sugar production culture medium taking sucrose as a substrate by using the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
in the step (3), respectively collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 9, 10 ℃ and 8000r/min by using 1mol/L NaOH, centrifuging for 30min, and collecting a first supernatant;
in the step (4), 1/10 volumes of 5 wt% trichloroacetic acid aqueous solution is added into the first supernatant, and the protein is denatured at 25 ℃ for 1.5 hours;
centrifuging at 3 deg.C and 6000r/min for 40min in step (5), collecting second supernatant, and adjusting pH to 7;
in the step (6), adding 3 times of volume of absolute ethyl alcohol to precipitate for 20 hours at 8 ℃ in a refrigerator;
in the step (7), centrifuging at 10 ℃ and 8000r/min for 30min, discarding supernatant, and freeze-drying precipitate to obtain crude exopolysaccharide powder.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 200mg/L of bacterial liquid.
Example 4
Extracellular polysaccharide was extracted from a bacterial solution obtained by culturing IPPBiotSR045 strain in 7L LB medium.
Extraction and quantification of crude exopolysaccharide as in example 1, the powder of crude exopolysaccharide was then dissolved in 50mL of ultra pure water.
Purification of exopolysaccharides
1.1 digestion of residual proteins
(1) Quantifying residual protein in the sample by using a BCA total protein quantification kit (Thermo);
(2) adding protease K with total residual protein mass of 1/10;
(3) carrying out enzymolysis for 2h in a water bath at 50 ℃, and analyzing whether protein is completely removed by SDS-PAGE;
(4) if the residual protein is not completely removed, adding protease K again for treatment until the protein removes the bacillus; and after the protein is completely removed, carrying out boiling water bath treatment for 15min, and inactivating the protease to obtain a crude extracellular polysaccharide solution with the protein removed for later purification.
1.2 desalination
The desalting column is HiPrepTM26/10 desaling, the purification procedure for deproteinized crude exopolysaccharide solution is as follows:
(1) centrifuging the crude extracellular polysaccharide solution with protein removed at 10000r/min for 20min to remove impurities;
(2) subjecting the desalting column HiPrepTM26/10 desaling loading protein purification systemIn the method, the ultra-pure water is used for cleaning the HiPrep containing desalting columnTM26/10 desaling-containing protein purification system
(3) Filtering the crude exopolysaccharide solution from which the protein is removed by using a 0.22 mu m filter membrane to obtain a filtered crude exopolysaccharide solution, and sampling 7mL of the filtered crude exopolysaccharide solution onto a desalting column at the flow rate of 10mL/min each time;
(4) according to UV490Respectively starting and ending the peak value and the peak position of the salt peak, and collecting samples flowing out of the desalting column to obtain a desalting chromatographic solution;
(5) finally, the protein purification system is cleaned by sequentially utilizing ultrapure water and 20% (v/v) ethanolAnd desalting column HiPrepTM 26/10 Desalting;
(6) The content of the extracellular polysaccharide in the desalted chromatographic solution is accurately detected by using a phenol-sulfuric acid method, and the concentration is about 20 mg/mL.
1.3 anion exchange chromatography
The anion exchange chromatography Column used was a 5mL HiTrap Q HP Column (Q-HP), and the purification procedure for the desalted chromatography solution was as follows:
(1) installing an anion exchange chromatography column Q-HP in a protein purification systemProtein purification system cleaned by ultrapure waterAt the same time, 2.0mol/L sodium chloride water solution is used for balancing the anion exchange chromatographic column Q-HP;
(2) according to the concentration of exopolysaccharide in the desalted chromatography liquid measured by phenol-sulfuric acid method (making the concentration between 10-15 mg/mL), a protein purification system is usedThe S1 sample pump is used for loading the desalted chromatographic solution to the anion exchange chromatographic column Q-HP, the sample loading amount is 15-20mL each time, the flow rate is 2.0mL/min, and meanwhile, a 96-hole deep-hole plate is used for manual collection, namely 1.7 mL/tube;
(3) after the sample loading is finished, washing the anion exchange chromatography column Q-HP by using ultrapure water with 5 times of column volume;
(4) linearly eluting with 2mol/L sodium chloride water solution at concentration of 0-100% for 20min at flow rate of 5mL/min to obtain eluate;
(5) finally, respectively cleaning the protein purification system by sequentially utilizing ultrapure water and 20% ethanolAnd an anion exchange chromatography column Q-HP;
(6) after the collection, detecting the hole position of the extracellular polysaccharide-containing eluent by using a phenol-sulfuric acid method (see figure 1), wherein the result shows that the single polysaccharide absorption peak appears, the salt ion concentration of the single polysaccharide absorption peak is between 5 and 10 percent, mixing the extracellular polysaccharide-containing hole position eluents, and concentrating the mixed eluents to 1/10 (about 30mL) of the original volume by using a freeze dryer to obtain the ion chromatography liquid.
1.4 gel filtration chromatography
The gel filtration chromatography column HiLoad 26/600 Sephacryl S-100column (Sephacryl S-100column, GE Healthcare Life Sciences) was used, and the purification procedure for the ion chromatography liquid was as follows:
(1) installing gel filtration chromatography column HiLoad 26/600 Seperdex 200 prep grade column in protein purification systemIn the middle, 0.15mol/L sodium chloride aqueous solution is used for cleaning the protein purification systemAnd a gel filtration chromatography column;
(2) taking 5mL of ion chromatography liquid each time, manually loading the sample to a gel filtration chromatography column, immediately collecting the sample, wherein the flow rate of the system is 0.5mL/min, collecting by using a 96-well plate, collecting 0.5mL of ion chromatography liquid in each well, collecting 180mL (namely 1.5 column volumes) in total, and stopping collecting to obtain gel chromatography liquid;
(3) finally, respectively cleaning the protein purification system and the gel filtration chromatographic column by sequentially utilizing ultrapure water and 20% ethanol;
(4) detecting the hole position of the gel chromatographic solution containing the extracellular polysaccharide by using a phenol-sulfuric acid method (see figure 2), wherein the result shows that the gel chromatographic solution is a single absorption peak, and combining the gel chromatographic solutions of the extracellular polysaccharide at the hole position of the single absorption peak to obtain the pure extracellular polysaccharide. And according to OD490nmAbsorbance values elution curves were plotted and single major peak positions were collected and either freeze-concentrated to 1/10 in bulk or freeze-dried to powder.
2 determination of molecular weight
And (3) determining the total sugar content, the protein content, the reducing sugar content and the uronic acid content of the pure extracellular polysaccharide obtained after gel filtration chromatography. The measurement method and the results are shown in Table 1:
TABLE 1
The results from table 1 show that the total sugar content of the purified exopolysaccharide purified from IPPBiotSR045 is 96.31%, and the uronic acid, protein and reducing sugar contents are all low, 1.38%, 0.13% and 2.18%, respectively. The full wavelength scan showed that the absorbance at 260nm and 280nm was less than 0.1 (fig. 3), i.e. the pure exopolysaccharide contained almost no nucleic acids and proteins, further indicating the high purity of the exopolysaccharide sample.
Molecular weight analysis Gel exclusion chromatography column Ohpak SB-805HQ (300X 8mm), Ohpak SB-804HQ (300X 8mm) and Ohpak SB-803HQ (300X 8mm) were connected in series according to the molecular weight of the extracellular polysaccharide preliminarily judged by the purification step, to obtain a series column, using a Gel chromatography-differential-multiangle laser light scattering system (GPC-RI-MALS), wherein the laser light scattering detector was DAWN HELEOS II (Wyatt technology, CA, USA), and the differential detector was Optilab T-rEX (Wyatt technology, CA, USA). The specific experimental procedures are as follows:
(1) accurately weighing extracellular polysaccharide powder 10.0mg after gel filtration chromatography and freeze drying, and dissolving in 1.0mL of 0.1mol/L NaNO3In the water solution, then 14000r/min, centrifuging for 10min to obtain supernatant;
(2) filtering the supernatant with 0.22 μm filter membrane to load the serial column;
(3) the sample loading amount to the series column is 100 mu L in one time, and the mobile phase is 0.1mol/L NaNO3The flow rate is 0.4mL/min, and the column temperature is kept at 45 ℃;
(4) data were collected and analyzed using ASTR6.1(Wyatt technology corporation, USA) software.
The results show that: the extracellular polysaccharide has Mw of 66.2kDa, Mn of 42.7kDa and Mz of 87.6 kDa. The Polydispersity (Mw/Mn) is 1.55. In addition, the change trend of the multi-angle laser light scattering signal is completely consistent with that of the differential signal, which indicates that the molecular weight analysis of the extracellular polysaccharide is more accurate and indicates that the extracellular polysaccharide is single-component homogeneous polysaccharide.
3 analysis of monosaccharide composition
The monosaccharide composition analysis adopts a Thermo-ion exchange chromatography system (High-performance and-exchange chromatography, model ICS5000+, USA), and the liquid chromatography column is DionexTMCarboPacTMPA10(250 × 4.0mm, 10 μm), the specific experimental procedure was as follows:
(1) preparing a standard substance: preparing to weigh 100mg of different monosaccharide standards, which comprise: glucose, rhamnose, arabinose, galactose, xylose, mannose, fructose and glucuronic acid;
(2) drawing a standard curve: diluting the standard substance into 1, 10, 20, 30, 40 and 50 mu g/mL aqueous solution respectively, wherein the loading amount is 20 mu L, the A mobile phase is water, the B mobile phase is 100mM NaOH, the column temperature is kept at 30 ℃, and a curve is drawn according to the retention time and the peak height of each component in the system;
(3) weighing 5mg (+ -0.05 mg) of extracellular polysaccharide powder subjected to gel filtration chromatography and freeze drying, adding trifluoroacetic acid, hydrolyzing at 121 ℃ for 2h, blow-drying with nitrogen, then cleaning with methanol, blow-drying again, and repeating methanol cleaning-blow-drying for 2-3 times. Adding sterile water to dissolve to be detected;
(4) comparing the retention time of the exopolysaccharide with the retention time of the standard monosaccharide to determine the monosaccharide composition of the exopolysaccharide.
The monosaccharide composition analysis results of exopolysaccharides are shown in fig. 4, the retention time of each component in exopolysaccharides is compared with that of a standard sample, and the monosaccharide components of exopolysaccharides are mainly mannose, glucuronic acid, glucose and galactose, and the relative molar ratio of the monosaccharide components to the monosaccharides is 55.77: 5.67: 3.70: 1. thus, exopolysaccharide is a heteropolysaccharide.
Example 3
Respectively dissolving 40 micrograms and 80 micrograms of purified exopolysaccharide in 1mL of sterile water to obtain exopolysaccharide aqueous solution, spraying the exopolysaccharide aqueous solution on the soil surface near the roots of the rapes by 40 micrograms/strain and 80 micrograms/strain, and taking the sterile water as a control group. Three biological replicates per treatment. The sclerotinia sclerotiorum cake was inoculated to rape leaves 5 days after the rape roots were treated with exopolysaccharide or sterile water, and the spread of the disease was observed on the 0 th, 2 th, 5 th and 7 th days of the inoculation, and the spread of the disease of the leaves after the rape roots were treated with exopolysaccharide 40. mu.g/strain and sterile water is shown in FIG. 5. According to the figure 5, after 7 days of exopolysaccharide treatment, the growth state of the rape is good, the leaf spots are not enlarged, the rape leaf spots after sterile water treatment rapidly spread two days after receiving diseases, and the leaf curling phenomenon appears 7 days. The lesion diameter of rape leaves after being inoculated with sclerotinia sclerotiorum for 7 days after being treated by 40 mu g/strain and 80 mu g/strain of exopolysaccharide is measured, and the induced disease-resistant effect is calculated by a formula of (lesion diameter of a control group-lesion diameter of an experimental group)/lesion diameter of the control group multiplied by 100 percent, and the result is shown in table 2. LSD analysis shows that the two groups of extracellular polysaccharide treatment groups have significant difference with the control group, and the difference is more than 50%. In conclusion, the purified extracellular polysaccharide of the IPPBiotSR045 strain has obvious disease resistance induction capability.
TABLE 2 statistical results of the lesion diameter of rape leaves when inoculating sclerotinia sclerotiorum after EPS treatment
Note: each set of data represents the mean ± standard error of the three sets of duplicate data; lower case letters in the graph indicate significant differences at the p <0.05 level for one-way ANOVA analysis between treatments.
Example 4
Fluorescence quantitative PCR standard curve:
respectively amplifying an internal reference gene actin (using act35F and act143R primers, wherein the nucleotide sequence of act35F is shown as SEQ ID No.1, and the nucleotide sequence of act143R is shown as SEQ ID No. 2) and a salicylic acid signal path related gene BnWRKY70 (using wrk592F and wrk693R primers for amplification, wherein the nucleotide sequence of wrk592F is shown as SEQ ID No.3, the nucleotide sequence of wrk693R is shown as SEQ ID No. 4), a jasmonic acid signal path related gene BnHEL (using hel431R and hel549R primers for amplification, wherein the nucleotide sequence of hel431R is shown as SEQ ID No.5, and the nucleotide sequence of hel549R is shown as SEQ ID No. 6) by taking a rape genome as a template, and amplifying the internal reference gene actin, wherein the nucleotide sequence of act35 and the nucleotide sequence of the hel549R are shown as SEQ ID No.6 respectively, jasmonic acid and ethylene signal pathway related gene BnPDFF 1.2 (amplified by using pdf10F and pdf107R primers, wherein the nucleotide sequence of pdf10F is shown as SEQ ID No.7, and the nucleotide sequence of pdf107R is shown as SEQ ID No. 8.) was enriched and purified by 10 cycles of ordinary PCR amplification. And diluting the enriched and purified product in a gradient manner and then using the diluted product as a template for drawing a fluorescent quantitative PCR standard curve. The reaction system and conditions refer to the instructions of a SuperReal PreMix Plus (SYBR Green) kit, and the reference gene and the target gene are drawn into a double-standard curve and subjected to related gene transcription level analysis. And when the R value of the standard curve of the gene is more than 0.99, the requirement of subsequent experiments can be met.
Dissolving 40 mu g of exopolysaccharide in 1mL of sterile water to obtain an exopolysaccharide aqueous solution, spraying 40 mu g of exopolysaccharide per strain on the soil surface near the rape roots, and taking the sterile water as a control group. After the roots of the rapes are treated by exopolysaccharides or sterile water for 5 days, respectively taking rape leaves 0 day, 2 days, 5 days and 7 days after the treatment, extracting total RNA of the rape leaves by using a Trizol method, synthesizing cDNA by using a Promega reverse transcription kit, analyzing the transcription conditions of BnHEL, BnWRKY70 and BnPDF1.2 genes in the rape leaves 0 day, 2 days, 5 days and 7 days after the exopolysaccharides are applied by using fluorescence quantitative PCR (qRT-PCR), and taking actin as an internal reference gene.
The transcription conditions of the gene BnWRKY70 related to the salicylic acid signal pathway, the gene BnHEL related to the jasmonic acid signal pathway and the gene BnPDF1.2 related to the jasmonic acid and ethylene signal pathway after the roots of the rape are treated with the exopolysaccharide for 0 day, 2 days, 5 days and 7 days are shown in FIGS. 6 to 8. All data in the figure are mean ± standard error of three sets of duplicate data. And LSD in the one-way variance ANOVA is used for carrying out statistical analysis, and the result shows that the transcription level of the BnWRKY70 gene is basically unchanged after the rape roots are treated by the extracellular polysaccharide, and has no significant difference (p is more than 0.05) with the transcription level of the day 0; the BnHEL gene started up-regulated transcription 5 days after exopolysaccharide treatment (p ═ 0.1990), with more pronounced up-regulation at day 7 (p ═ 0.009), which was 1.63 and 2.96 times the relative transcription level at day 0, respectively; the bnpdf1.2 gene was up-regulated at day 2 after exopolysaccharide treatment (p 0.102), and at day 7, the transcript level was significantly different from that at day 0 (p 0.005), which was 2.22 times that at day 0. In summary, the jasmonic acid and ethylene signaling pathways were activated after treatment of canola roots with exopolysaccharides.
While the invention has been described with reference to specific embodiments, those skilled in the art will appreciate that various changes can be made without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, and method to the essential scope and spirit of the present invention. All such modifications are intended to be included within the scope of the present invention as defined in the appended claims.
Sequence listing
<110> institute of plant protection of Chinese academy of agricultural sciences
<120> an exopolysaccharide extract, exopolysaccharide and uses thereof
<130> LHA2160512
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gtgccgatct acgaaggtta tg 22
<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
gtaccctctc tcggtgagaa t 21
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
aagcaagtgc agaagctaga g 21
<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
ggcttgatct tgggtgatac tt 22
<210> 5
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
ggtgaggaac acaaggacta at 22
<210> 6
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
gccatcacca tcggtatcta tt 22
<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
ttcctcacac accacacata c 21
<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111422635.7A CN114230681A (en) | 2021-11-26 | 2021-11-26 | A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111422635.7A CN114230681A (en) | 2021-11-26 | 2021-11-26 | A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114230681A true CN114230681A (en) | 2022-03-25 |
Family
ID=80751424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111422635.7A Pending CN114230681A (en) | 2021-11-26 | 2021-11-26 | A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114230681A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116590373A (en) * | 2023-06-29 | 2023-08-15 | 广东海洋大学 | A kind of exopolysaccharide of fermented Lactobacillus mucus, preparation method and application |
CN118360180A (en) * | 2023-12-27 | 2024-07-19 | 盐城师范学院 | Klebsiella YCTU3162, extracellular polysaccharide Flocan produced by same and application thereof |
CN119856718A (en) * | 2025-03-25 | 2025-04-22 | 中国农业科学院植物保护研究所 | Application of exopolysaccharide or extract containing exopolysaccharide in improving sunlight or ultraviolet degradation resistance of insecticidal protein |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2567722A1 (en) * | 2004-05-27 | 2005-12-08 | Novozymes Biopolymer A/S | A dried and agglomerated hyaluronic acid product |
CN105007741A (en) * | 2012-12-03 | 2015-10-28 | 拜耳作物科学股份公司 | Composition comprising a biological control agent and a fungicide |
AU2015263304A1 (en) * | 2014-05-23 | 2016-12-22 | Basf Se | Mixtures comprising a bacillus strain and a pesticide |
CN106432530A (en) * | 2016-11-24 | 2017-02-22 | 福建省农业科学院土壤肥料研究所 | Extracting technology of dictyophora indusiata volva colloid polysaccharide |
CN107058172A (en) * | 2017-02-27 | 2017-08-18 | 中国农业科学院植物保护研究所 | A kind of bacillus thuringiensis and its application |
US20180092363A1 (en) * | 2016-10-05 | 2018-04-05 | Fmc Corporation | Bacillus thuringiensis rti545 compositions and methods of use for benefiting plant growth and controlling plant pests |
CN110089526A (en) * | 2019-04-24 | 2019-08-06 | 中国农业科学院植物保护研究所 | Plant polyose is promoting application and composition in thuringiensis prevention and treatment insect |
CN112608871A (en) * | 2021-01-12 | 2021-04-06 | 江南大学 | Method for producing probiotic active substances by high-density fermentation of bacillus thuringiensis |
CN113402626A (en) * | 2021-07-12 | 2021-09-17 | 中国科学院华南植物园 | Nymphaea hybrid polysaccharide extract and preparation method and application thereof |
-
2021
- 2021-11-26 CN CN202111422635.7A patent/CN114230681A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2567722A1 (en) * | 2004-05-27 | 2005-12-08 | Novozymes Biopolymer A/S | A dried and agglomerated hyaluronic acid product |
CN105007741A (en) * | 2012-12-03 | 2015-10-28 | 拜耳作物科学股份公司 | Composition comprising a biological control agent and a fungicide |
AU2015263304A1 (en) * | 2014-05-23 | 2016-12-22 | Basf Se | Mixtures comprising a bacillus strain and a pesticide |
US20180092363A1 (en) * | 2016-10-05 | 2018-04-05 | Fmc Corporation | Bacillus thuringiensis rti545 compositions and methods of use for benefiting plant growth and controlling plant pests |
CN106432530A (en) * | 2016-11-24 | 2017-02-22 | 福建省农业科学院土壤肥料研究所 | Extracting technology of dictyophora indusiata volva colloid polysaccharide |
CN107058172A (en) * | 2017-02-27 | 2017-08-18 | 中国农业科学院植物保护研究所 | A kind of bacillus thuringiensis and its application |
CN110089526A (en) * | 2019-04-24 | 2019-08-06 | 中国农业科学院植物保护研究所 | Plant polyose is promoting application and composition in thuringiensis prevention and treatment insect |
CN112608871A (en) * | 2021-01-12 | 2021-04-06 | 江南大学 | Method for producing probiotic active substances by high-density fermentation of bacillus thuringiensis |
CN113402626A (en) * | 2021-07-12 | 2021-09-17 | 中国科学院华南植物园 | Nymphaea hybrid polysaccharide extract and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
MEILING WANG ET AL.: ""Screening of Bacillus thuringiensis strains to identify new potential biocontrol agents against Sclerotinia sclerotiorum and Plutella xylostella in Brassica campestris L."", 《BIOLOGICAL CONTROL》 * |
MEILING WANG ET AL.: ""Structure characteristics and function of a novel extracellular polysaccharide from Bacillus thuringiensis strain 4D19"", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》 * |
王美玲: ""苏云金芽胞杆菌诱导油菜抗菌核病的研究"", 《中国优秀博硕士学位论文全文数据库(硕士)农业科技辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116590373A (en) * | 2023-06-29 | 2023-08-15 | 广东海洋大学 | A kind of exopolysaccharide of fermented Lactobacillus mucus, preparation method and application |
CN116590373B (en) * | 2023-06-29 | 2023-11-17 | 广东海洋大学 | Fermented lactobacillus mucilaginosus extracellular polysaccharide, preparation method and application |
CN118360180A (en) * | 2023-12-27 | 2024-07-19 | 盐城师范学院 | Klebsiella YCTU3162, extracellular polysaccharide Flocan produced by same and application thereof |
CN119856718A (en) * | 2025-03-25 | 2025-04-22 | 中国农业科学院植物保护研究所 | Application of exopolysaccharide or extract containing exopolysaccharide in improving sunlight or ultraviolet degradation resistance of insecticidal protein |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114230681A (en) | A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof | |
CN113564069B (en) | Bifidobacterium longum, extracellular polysaccharide of bifidobacterium longum, and extraction method and application thereof | |
CN106755188A (en) | The preparation method and brown alga oligose of a kind of brown alga oligose monomer | |
CN111440885B (en) | Molecular marker for identifying sanzan glue and synthetic bacteria thereof, and preparation and application thereof | |
CN109182486B (en) | Primer of molecular marker for identifying sanzan gum, gellan gum and welan gum, molecular marker and application | |
CN104232548B (en) | Exopolysaccharide generated by pseudomonas, culture method and application | |
Sullivan et al. | Characterization and poly (adenylic acid) content of Ehrlich ascites cell ribonucleic acids fractionated on unmodified cellulose columns | |
CN1178693C (en) | A kind of preparation method of earthworm antimicrobial peptide | |
CN113151050A (en) | A strain of Sphingomonas and its application | |
CN118978610A (en) | Extract containing extracellular polysaccharide, extracellular polysaccharide and composition | |
CN100475971C (en) | A kind of preparation method of exopolysaccharide of deep-sea cold suitable microorganism | |
CN111893150A (en) | A kind of sucrose-induced bacterial solid-state fermentation to produce kola acid and purification method | |
CN113817078B (en) | Poplar yellow fungus polysaccharide with anti-colorectal cancer effect based on immune regulation and control and application thereof | |
CN104651284B (en) | Sphingol single-cell T 3 and its method for common fermentation production biological polyoses and poly- β hydroxybutyric acids | |
CN104231106B (en) | Paenibacillus exopolysaccharide and preparation method and application of paenibacillus exopolysaccharide | |
CN110106121A (en) | A kind of lactobacillus plantarum of extracellular polysaccharide | |
CN113265337A (en) | Marine aspergillus versicolor and isolated culture method and application thereof | |
CN102154405B (en) | Preparation method of hyaluronic acid | |
Fedonenko et al. | Involvement of the lipopolysaccharides of Azospirilla in the interaction with wheat seedling roots | |
Morris et al. | Possible biological roles for Rhizobium leguminosarum extracellular polysaccharide and cyclic glucans in bacteria-plant interactions for nitrogen-fixing bacteria | |
CN113956372B (en) | Molecular marker and application of a kind of high acyl trizan gum and its production strain | |
CN108060187B (en) | A kind of polysaccharide and its preparation method and application | |
CN114958989B (en) | Treatment fluid, amplification system and kit for rapid and direct double PCR amplification | |
CN106011197A (en) | Microorganism-derived algin and preparation and application thereof | |
Jindal et al. | Isolation of microbial polysaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220325 |